In Other News

• Siemens Healthcare Partners with Pfizer to Develop Companion Diagnostics

• Analysis of Molecular Diagnostics Business Published

• Horizon and Transgenomic to Collaborate on Genetic Diagnostic Tests

• Global Market for Automated Tissue Diagnostics Expected to Surge

• Innova and TGR Enter Co-Marketing Agreement for Complementary Core Biotechnologies

• GE’s USD 1 billion Biotech Acquisitions from Thermo Fisher to Boost Discovery of New Drugs and Diagnostic Products

• The Carlyle Group Acquires J&J Diagnostics Business

• Amgen and Illumina Collaborate on Oncology Companion Diagnostic Test

• Cancer Origin Test Covered by Large Private Health Insurer

• Clinical Lab Services Industry Endeavors to Overcome Reimbursement Cuts

• Horizon and AstraZeneca Announce Oncology Agreement

• Thermo Fisher Sells Businesses Before Purchase of Life Technologies

• Dynamic Trends Seen in Clinical Laboratory Services

• bioMérieux Finalizes Acquisition of BioFire

• GE to Expand in Biomedical and Life Sciences with Strategic Acquisitions from Thermo Fisher Scientific

• Collaboration to Examine the Utility of KRAS Mutations in Urine

• Veterinary Diagnostics Revenue Increasing Faster Than Overall IVD

• Siemens Enters Collaboration Agreement with Pfizer

• Infectious Disease IVD Sector Unaffected by Vaccine Development

• Global Healthcare’s Three Big Forecasts: mHealth, Cloud Healthcare, and Regulator Environments

• Novartis Sells Blood Transfusion Testing Unit

• Ventana and Incyte Collaborate on Companion Diagnostic tests

• Multiplex HIV-Syphilis Assay Launched